Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes

Atherosclerosis. 2005 Dec;183(2):367-8. doi: 10.1016/j.atherosclerosis.2005.08.012. Epub 2005 Sep 13.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers / blood
  • Creatinine / blood*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Female
  • Glomerular Filtration Rate / drug effects
  • Homocysteine / blood*
  • Homocysteine / drug effects
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Kidney / drug effects
  • Kidney / physiopathology
  • Male
  • Middle Aged
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use*

Substances

  • Biomarkers
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Homocysteine
  • Creatinine